Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ARDX Ardelyx > Detailed Quotes

ARDX Ardelyx

1.130
-0.050-4.24%
Close 09/29 16:00 ET
1.140
+0.010+0.88%
Post Mkt Price 09/29 19:43 ET
High
1.170
Open
1.160
Turnover
2.33M
Low
1.110
Pre Close
1.180
Volume
2.05M
Market Cap
190.58M
P/E(TTM)
Loss
52wk High
1.920
Shares
168.65M
P/E(Static)
Loss
52wk Low
0.490
Float Cap
169.87M
Bid/Ask %
-88.64%
Historical High
35.480
Shs Float
150.33M
Volume Ratio
0.81
Historical Low
0.490
Dividend TTM
--
Div Yield TTM
--
P/B
3.59
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.37%
Amplitude
5.09%
Avg Price
1.133
Lot Size
1
Float Cap
169.87M
Bid/Ask %
-88.64%
Historical High
35.480
Shs Float
150.33M
Volume Ratio
0.81
Historical Low
0.490
Dividend TTM
--
P/B
3.59
Dividend LFY
--
Turnover Ratio
1.37%
Amplitude
5.09%
Avg Price
1.133
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Ardelyx, Inc. is a biopharmaceutical company. engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.
CEO: Mr. Michael G. Raab
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...